Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Tapan M. Kadia, MD, Hongbing Ma, MD PhD, Ke Zeng, MD PhD, Mitsutaka Nishimoto, MD PhD, Mi-Ae Lyu, PhD, Meixian Huang, Musa Yilmaz, MD, Courtney D. DiNardo, MDMSc, Ghayas C. Issa, MD, Simrit Parmar, MBBS, Swami P. Iyer, MD, Parameswaran Hari, MBBS, MD, Naval G. Daver, MD, Elias Jabbour, MD, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1221.

https://doi.org/10.1182/blood-2019-127702

Published: 2019

Journal Articles

Plasma Biomarker Association with Response in Acute GVHD Subjects Treated with the Combination of Itacitinib and Corticosteroids in a Phase 1 Clinical Trial

Michael A. Pratta, MSc, Hao Liu, PhD, Michael C. Arbushites, Robert C Newton, PhD, Michael D. Howell, PhD

Blood (2018) 132 (Supplement 1): 4559.

https://doi.org/10.1182/blood-2018-99-116330

Published: 2018

Journal Articles

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

Marie Robin, MD PhD, Raphael Porcher, PhD, Laetitia Taurines, Bastien Oriano, Regis Peffault De Latour, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Nathalie Dhedin, MD, Christine Chomienne, MD PhD, Gérard Socié, MDPhD, Marie-Hélène Schlageter, PharmD

Blood (2017) 130 (Supplement 1): 4480.

https://doi.org/10.1182/blood.V130.Suppl_1.4480.4480

Published: 2017

Journal Articles

Composite Biomarker Panel in Prediction of Severity and Diagnosis of Acute GvHD with T- Depleted Allogeneic Stem Cell Transplants- Single Centre Pilot Study

San San Min, MBBS, MSc, FRCPath, Varun Mehra, MBBS, MRCP(UK), FRCPath, Jennifer Clay, Gemma Cross, Abdel Douiri, PhD, Tracy Dew, Victoria T Potter, Tanya Basu, MRCP, MBBS, PhDMA, Roy Sherwood, BSc, MSc, DPhil, Royce Vincent, MBBS, MSc, MD FRCPath, M. Mansour Ceesay, MRCP, FRCPath, MDRes), Antonio Pagliuca, MBBS MA FRCP FRCPath

Blood (2016) 128 (22): 2234.

https://doi.org/10.1182/blood.V128.22.2234.2234

Published: 2016

Journal Articles

Prognostic Value Of Plasma Biomarkers Compared To Urinary Proteome Patterns

Christin Human, Sylvia Borchers, PhD, Michael Stadler, MD, Helmut Diedrich, Jürgen Krauter, MD, PhD, Christine Falk, Arnold Ganser, Eva M Weissinger, MD

Blood (2013) 122 (21): 4593.

https://doi.org/10.1182/blood.V122.21.4593.4593

Published: 2013

Journal Articles

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

Minoo Battiwalla, MD, MS, Fang Yin, MD, Sawa Ito, Xingmin Feng, PhD, Fariba Chinian, M.S., J. Joseph Melenhorst, PhD, Eleftheria K Koklanaris, BSN, Marianna Sabatino, David Stroncek, MD, Leigh Samsel, MS, Jeffrey K. Klotz, MD, Nancy F. Hensel, Pamela Robey, PhD, A. John Barrett, MD

Blood (2013) 122 (21): 3282.

https://doi.org/10.1182/blood.V122.21.3282.3282

Published: 2013

Journal Articles

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

Doris M Ponce, MD, Patrick Hilden, MS, Christy Mumaw, MS, Sean Devlin, PhD, Marissa N Lubin, BA, Katherine L Evans, BA, Susan Prockop, MD, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Sergio A Giralt, MD, Marcel R.M. van den Brink, MD, PhD, Sophie Paczesny, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 146.

https://doi.org/10.1182/blood.V122.21.146.146

Published: 2013

Journal Articles

A Biomarker-Based Grading System At Onset Of GvHD Predicts NRM Better Than The Modified Glucksberg Grading System

John E. Levine, M.D., M.S., Andrew C Harris, M.D., Austin Taylor, Thomas M. Braun, Ph.D., John Magenau, M.D., James L.M. Ferrara, M.D., D.Sc.

Blood (2013) 122 (21): 145.

https://doi.org/10.1182/blood.V122.21.145.145

Published: 2013

Journal Articles

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Thomas M. Braun, Ph.D., Daniel R. Couriel, M.D., Sung W. Choi, M.D., Carrie Kitko, M.D., Steven Goldstein, John M. Magenau, M.D., Sophie Paczesny, M.D., Ph.D, Attaphol Pawarode, Pavan Reddy, M.D., Gregory A. Yanik, Austin Taylor, James Connelly, M.D., Craig A. Byersdorfer, M.D., Ph.D., John E. Levine, M.D., M.S.

Blood (2012) 120 (21): 463.

https://doi.org/10.1182/blood.V120.21.463.463

Published: 2012

Journal Articles

Cytokine Environement Analysis During Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases

Fabien Touzot, MD, PhD, Bryan Fiema, Sophie Paczesny, M.D., Ph.D, Isabelle Andre-Schmutz, PhD, Dominique Helley, MD, PhD, Despina Moshous, MD, PhD, Corinne De Chappedelaine, Stephane Blanche, MD, Alain Fischer, MD/PhD, Marina Cavazzana-Calvo, MD, PhD

Blood (2012) 120 (21): 4484.

https://doi.org/10.1182/blood.V120.21.4484.4484

Published: 2012

Journal Articles

Investigation of Urine/Plasma Biomarkers to Predict Tolerance and Graft-Versus-Host Disease Post Allogeneic Stem Cell Transplantation.

Christin Human, Sylvia Borchers, PhD, Michael Stadler, MD, Helmut Diedrich, Jürgen Krauter, MD, PhD, Christine Falk, Arnold Ganser, Eva M Mischak-Weissinger, MD

Blood (2012) 120 (21): 3049.

https://doi.org/10.1182/blood.V120.21.3049.3049

Published: 2012

Journal Articles

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Mark T. Vander Lugt, M.D., Thomas Braun, PhD, James L.M. Ferrara, MD, DSc, Samir Hanash, M.D., Ph.D., John E. Levine, MD, MS, Chee-Hong Wang, Qing Zhang, Alice Chin, Andrew C. Harris, M.D., Sung W.J. Choi, M.D., Daniel Couriel, MD, Pavan Reddy, M.D., Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): 152.

https://doi.org/10.1182/blood.V118.21.152.152

Published: 2011

Journal Articles

Membrane-Associated Proteinase 3 on Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation

Tian-Hui Yang, MD, PhD, Karen Clise-Dwyer, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD

Blood (2011) 118 (21): 1916.

https://doi.org/10.1182/blood.V118.21.1916.1916

Published: 2011

Journal Articles

Discovery and Validation of Graft-Versus-Host Disease Biomarkers

Sophie Paczesny, MD, PhD

Blood (2011) 118 (21): SCI-50.

https://doi.org/10.1182/blood.V118.21.SCI-50.SCI-50

Published: 2011

Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Blood (2010) 116 (21): 675.

https://doi.org/10.1182/blood.V116.21.675.675

Published: 2010

Journal Articles

Neutrophil Proteinase (PR3) Regulates Neutrophil Transendothelial Cell Migration.

Christopher Kuckleburg, PhD, Sarah Tilkens, Sentot Santoso, PhD, Peter J. Newman, PhD

Blood (2010) 116 (21): 1492.

https://doi.org/10.1182/blood.V116.21.1492.1492

Published: 2010

Journal Articles

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Tian-Hui Yang, MD., PhD, Gheath Alatrash, DO, PhD, Karen Clise-Dwyer, PhD, Kathryn Quintanilla, MS, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 2099.

https://doi.org/10.1182/blood.V116.21.2099.2099

Published: 2010

Journal Articles

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

Erica Dander, PhD, Giovanna Lucchini, MD, Paola Vinci, Martino Introna, MD, Sonia Bonanomi, MD, Adriana Balduzzi, MD, Giuseppe Gaipa, PhD, Paolo Perseghin, MD, Francesca Masciocchi, Chiara Capelli, PhD, Josée Golay, PhD, Alessandra Algarotti, MD, Alessandro Rambaldi, MD, Attilio Rovelli, MD, Andrea Biondi, MD, Ettore Biagi, MD, Giovanna D'Amico, PhD

Blood (2010) 116 (21): 2306.

https://doi.org/10.1182/blood.V116.21.2306.2306

Published: 2010

Journal Articles

Elafin Is a Biomarker of Graft Versus Host Disease of the Skin

Sophie Paczesny, MD, PhD., John E. Levine, MD, Jason Hogan, PhD., Jeffrey Crawford, Thomas Braun, PhD, Hong Wang, PhD., Vitor Faca, PhD, Qing Zhang, Sharon Pitteri, PHD, Alice Chin, Sung Choi, MD, Carrie Kitko, MD, Oleg I. Krijanovski, PhD, MD, Pavan Reddy, MD, Shin Mineishi, MD, Joel Whitfield, Dawn Jones, RN, Samir Hanash, MD, PhD, James L.M. Ferrara, MD

Blood (2008) 112 (11): 716.

https://doi.org/10.1182/blood.V112.11.716.716

Published: 2008

Journal Articles

Proteinase 3 Mediates Direct Inhibition of CD4 and CD8 T Lymphocyte Proliferation by Inducing Enzyme-Independent G0/G1 Cell Cycle Arrest

Tian-Hui Yang, MD., PhD, Kathryn E Quintanilla, Amy M Cortez, Jeffrey J. Molldrem, MD

Blood (2008) 112 (11): 4916.

https://doi.org/10.1182/blood.V112.11.4916.4916

Published: 2008

NARROW

Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis

Plasma Biomarker Association with Response in Acute GVHD Subjects Treated with the Combination of Itacitinib and Corticosteroids in a Phase 1 Clinical Trial

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

Composite Biomarker Panel in Prediction of Severity and Diagnosis of Acute GvHD with T- Depleted Allogeneic Stem Cell Transplants- Single Centre Pilot Study

Prognostic Value Of Plasma Biomarkers Compared To Urinary Proteome Patterns

Phase 1 Trial Of Bone Marrow Stromal Cells (Bone Marrow-derived MSCS) To Treat Tissue Damage In Allogeneic Stem Cell Transplant Recipients: Biological Markers Correlate With Clinical Responses and Survival

High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality After Double-Unit Cord Blood Transplantation

A Biomarker-Based Grading System At Onset Of GvHD Predicts NRM Better Than The Modified Glucksberg Grading System

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Cytokine Environement Analysis During Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases

Investigation of Urine/Plasma Biomarkers to Predict Tolerance and Graft-Versus-Host Disease Post Allogeneic Stem Cell Transplantation.

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Membrane-Associated Proteinase 3 on Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation

Discovery and Validation of Graft-Versus-Host Disease Biomarkers

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Neutrophil Proteinase (PR3) Regulates Neutrophil Transendothelial Cell Migration.

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

Elafin Is a Biomarker of Graft Versus Host Disease of the Skin

Proteinase 3 Mediates Direct Inhibition of CD4 and CD8 T Lymphocyte Proliferation by Inducing Enzyme-Independent G0/G1 Cell Cycle Arrest

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only